Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

AACR 2020 Resources

  • Apr 27, 2020–Jul 26, 2020

Because we won’t be able to meet you in person at our booth this year, we’re bringing our booth to you. Explore our virtual booth for new products, instruments, posters, online presentation and resources.

Promega is committed to supporting SARS-CoV-2 research and vaccine development. Learn More

Looking to Connect?

We would love to speak with you, one on one, about your research interests. Please submit your information and a Promega representative will be in contact with you shortly.

Submit Your Information

Product Information & Resources

Learn more about how Promega is helping advance cancer research, from the laboratory to the clinic, with innovative products and technology platforms.

Clinical Research

With many urgent challenges and uncertain outcomes, molecular oncology research requires comprehensive support and resources. We believe in science-driven solutions and personalized service for scientists working with any type of cancer research. Explore our collection of molecular oncology resources, or chat with a scientist to work through your specific needs.

What is Microsatellite Instability (MSI)?


We provide a broad portfolio of functional bioassays and monoclonal antibody characterization tools to accelerate your biologics drug discovery and development. Our custom assay development team can partner with drug developers in the early stages of biologic development to ensure that our bioassays meet your needs.

Biologics for Drug Discovery

Cell Viability, Toxicity, & Metabolism

We offer many products to assist your cell biology studies. Our products include assays to monitor cell health and apoptosis, oxidative stress, inflammation and changes in energy metabolism. All our kits are scalable for high-throughput screening and drug discovery applications, and many of our assays have been validated for use in 3D culture.

Cell Viability and Cytotoxicity

Protein Dynamics & Cell Signaling

Promega’s unique portfolio of products to study real-time protein dynamics are based on innovative bioluminescent technology. These methods are useful for detecting and studying proteins at endogenous expression levels.

New Products

Lumit™ Immunoassays

Replace conventional immunoassays, such as Western blots and ELISAs, with new Lumit™ Immunoassays. These assays offer direct luminescence measurement in cell culture, broad dynamic range, and can be completed in as little as 30 minutes.

Lumit™ Immunoassays are available for a range of applications, including protein phosphorylation and pathway analysis, FcRn binding, cytokine detection, metabolite research, and more. You can also build your own Lumit™ immunoassays with our labeling and detection kits.

Our Lumit™ Immunoassay webinar introduces the technolgy and provides examples of applications for cytokine detection, signaling pathway analysis and FcRn binding.

View Webinar On Demand

Lumit immunoassay principle

General principle of a Lumit™ Immunoassay. Antibodies are chemically labeled with the small and large subunits of NanoLuc® Luciferase, known as SmBiT and LgBiT, respectively. In the presence of an analyte, the two antibodies come into close proximity, allowing SmBiT and LgBiT to form an active enzyme and generate a bright luminescence signal.

Technology Platforms to Support Cancer Research

Spectrum Compact CE Instrument for Sanger Sequencing

Spectrum Compact CE System
One compact CE system optimized for fragment analysis

Request More Info
GloMax Discover System Multimode Plate Reader

GloMax® Discover Microplate Reader
State-of-the-art luminescence, fluorescence, UV-visible absorbance, BRET and FRET detection

Request More Info

Maxwell® RSC 48 Instrument
High-quality nucleic acid purification with minimal steps and less hands-on time

Request More Info

Don’t Miss Our Posters at AACR, June 22–24, 2020!

Quantitative cell-based reporter bioassays for functional characterization of immunotherapeutic biologics targeting co-stimulatory and co-inhibitory immune checkpoint receptors
Presented by: Gopal Krishnan, Sr. Global Product Manager, Biologics

Novel bioluminescent bioassays for the discovery and development of molecular and cellular T cell redirecting cancer therapy
Presented by: Julia Gilden, Sr. Research Scientist, R&D Integrated Biology

Cell-based reporter bioassays for development of Fc-functional and Fc-silent SIRPa/CD47 checkpoint inhibitors
Presented by: Jonathan Mitchell, Sr. Research Scientist, R&D Integrated Biology

Reproducible, MoA-reflecting reporter-based bioassays to enable drug development of biosimilars and biobetters
Presented by: Steve Edenson, Strategic Collaboraions Manager, Life Sciences

Rapid and sensitive determination of cytokine release from cells without the need for sample transfer
Presented by: Dan Lazar, Sr. Research Scientist, R&D Assay Design

Real-time monitoring of PROTAC and molecular glue targeted degradation in living cells 
Presented by: Kristin Riching, Sr. Research Scientist, R&D Protein & Nucleic Acid

Targeted degradation of endogenously tagged proteins for phenotypic studies using HaloPROTAC3 and HaloTag technologies
Presented by: Chris Heid, Sr. Global Commercialization Marketing Manager, Pharma/Biotech

A real-time extracellular ATP assay to identify modulators of the innate immune response 
Presented by: Drew Niles, Sr. Research Scientist, R&D Assay Design

A homogenous PBMC ADCC bioassay enables bridging studies with ADCC reporter bioassays in immunotherapy monoclonal antibody development 
Presented by: Vanessa Ott, Marketing Manager, Biologics

Examination of clinically relevant inhibitor selectivity in live cells across the CDK family 
Presented by: Jim Vasta, Sr. Research Scientist, R&D Integrated Biology

A Live Cell Method to Assess E3 Ligase and Target Protein Occupancy for PROTACs 
Presented by: Richard Somberg, Director Pharma/Biotech Market Segment

Microsatellite analysis on a novel small footprint capillary electrophoresis instrument 
Presented by: Lance Brown, Sr. Global Commercialization Marketing Manager, Clinical Diagnostics

A performance characterization of microsatellite instability and mismatch repair testing methods in endometrial samples 
Presented by: Samantha Lewis, Clinical Development Specialist, Clinical Diagnostics